These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 24647221)

  • 1. Metabolic syndrome and its factors affect cognitive function in chronic schizophrenia complicated by metabolic syndrome.
    Li C; Zhan G; Rao S; Zhang H
    J Nerv Ment Dis; 2014 Apr; 202(4):313-8. PubMed ID: 24647221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A twenty-four-week, open-label study on ziprasidone's efficacy and influence on glucolipid metabolism in patients with schizophrenia and metabolic disorder.
    Li CH; Shi L; Zhan GL; Rao SZ; Zhang H
    Eur Rev Med Pharmacol Sci; 2013 Aug; 17(16):2136-40. PubMed ID: 23893178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive functioning in schizophrenia and bipolar disorder: comparison of performance on the Repeatable Battery for the Assessment of Neuropsychological Status.
    Dickerson F; Boronow JJ; Stallings C; Origoni AE; Cole SK; Yolken RH
    Psychiatry Res; 2004 Nov; 129(1):45-53. PubMed ID: 15572184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gender differences in never-medicated first-episode schizophrenia and medicated chronic schizophrenia patients.
    Zhang XY; Chen DC; Xiu MH; Yang FD; Haile CN; Kosten TA; Kosten TR
    J Clin Psychiatry; 2012 Jul; 73(7):1025-33. PubMed ID: 22901352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cigarette smoking, psychopathology and cognitive function in first-episode drug-naive patients with schizophrenia: a case-control study.
    Zhang XY; Chen DC; Xiu MH; Haile CN; He SC; Luo X; Zuo L; Rosenheck R; Kosten TA; Kosten TR
    Psychol Med; 2013 Aug; 43(8):1651-60. PubMed ID: 23149169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender differences in cognitive function of patients with chronic schizophrenia.
    Han M; Huang XF; Chen DC; Xiu MH; Hui L; Liu H; Kosten TR; Zhang XY
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Dec; 39(2):358-63. PubMed ID: 22820676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Posttraumatic stress disorder, cognitive function and quality of life in patients with schizophrenia.
    Fan X; Henderson DC; Nguyen DD; Cather C; Freudenreich O; Evins AE; Borba CP; Goff DC
    Psychiatry Res; 2008 May; 159(1-2):140-6. PubMed ID: 18423611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma total antioxidant status and cognitive impairments in schizophrenia.
    Zhang XY; Chen DC; Xiu MH; Tang W; Zhang F; Liu L; Chen Y; Liu J; Yao JK; Kosten TA; Kosten TR
    Schizophr Res; 2012 Aug; 139(1-3):66-72. PubMed ID: 22555016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TCF4 gene polymorphism is associated with cognition in patients with schizophrenia and healthy controls.
    Hui L; Rao WW; Yu Q; Kou C; Wu JQ; He JC; Ye MJ; Liu JH; Xu XJ; Zheng K; Ruan LN; Liu HY; Hu WM; Shao TN; AngRabanes MB; Soares JC; Zhang XY
    J Psychiatr Res; 2015 Oct; 69():95-101. PubMed ID: 26343600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of tapering of long-term benzodiazepines on cognitive function in patients with schizophrenia receiving a second-generation antipsychotic.
    Kitajima R; Miyamoto S; Tenjin T; Ojima K; Ogino S; Miyake N; Fujiwara K; Funamoto Y; Arai J; Tsukahara S; Ito Y; Tadokoro M; Anai K; Kaneda Y; Yamaguchi N
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Mar; 36(2):300-6. PubMed ID: 22122880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations between components of metabolic syndrome and cognition in patients with schizophrenia.
    Goughari AS; Mazhari S; Pourrahimi AM; Sadeghi MM; Nakhaee N
    J Psychiatr Pract; 2015 May; 21(3):190-7. PubMed ID: 25955261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered interleukin-18 levels are associated with cognitive impairment in chronic schizophrenia.
    Wu JQ; Chen DC; Tan YL; Tan SP; Xiu MH; Wang ZR; Yang FD; Soares JC; Zhang XY
    J Psychiatr Res; 2016 May; 76():9-15. PubMed ID: 26866662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of life and cognitive dysfunction in people with schizophrenia.
    Ueoka Y; Tomotake M; Tanaka T; Kaneda Y; Taniguchi K; Nakataki M; Numata S; Tayoshi S; Yamauchi K; Sumitani S; Ohmori T; Ueno S; Ohmori T
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jan; 35(1):53-9. PubMed ID: 20804809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognition impairment in schizophrenia patients with tardive dyskinesia: association with plasma superoxide dismutase activity.
    Wu JQ; Chen DC; Tan YL; Tan SP; Wang ZR; Xiu MH; Yang FD; Zhang XY
    Schizophr Res; 2014 Jan; 152(1):210-6. PubMed ID: 24325977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gender difference in association of cognition with BDNF in chronic schizophrenia.
    Zhang XY; Chen DC; Tan YL; Tan SP; Wang ZR; Yang FD; Xiu MH; Hui L; Lv MH; Zunta-Soares GB; Soares JC
    Psychoneuroendocrinology; 2014 Oct; 48():136-46. PubMed ID: 24999831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brief cognitive assessment in schizophrenia: normative data for the Repeatable Battery for the Assessment of Neuropsychological Status.
    Wilk CM; Gold JM; Humber K; Dickerson F; Fenton WS; Buchanan RW
    Schizophr Res; 2004 Oct; 70(2-3):175-86. PubMed ID: 15329294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical symptoms and cognitive impairment associated with male schizophrenia relate to plasma manganese superoxide dismutase activity: a case-control study.
    Zhang XY; Chen DC; Xiu MH; Tan YL; Yang FD; Zhang LY; Zhang LY; Haile CN; Kosten TR
    J Psychiatr Res; 2013 Aug; 47(8):1049-53. PubMed ID: 23611682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of switching to long-acting injectable risperidone from oral atypical antipsychotics on cognitive function in patients with schizophrenia.
    Kim SW; Shin IS; Kim JM; Lee SH; Lee YH; Yang SJ; Yoon JS
    Hum Psychopharmacol; 2009 Oct; 24(7):565-73. PubMed ID: 19790174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between psychopathology and cognitive functioning in schizophrenia.
    Bozikas VP; Kosmidis MH; Kioperlidou K; Karavatos A
    Compr Psychiatry; 2004; 45(5):392-400. PubMed ID: 15332203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.